Steve Weitman
Impact in
- Pharmaceutical Science top 1%
- Advanced Drug Delivery Systems
- Molecular Medicine top 2%
- Hydrogels: synthesis, properties, applications
Papers in
-
- Cancer therapeutics and mechanisms 6
- RNA Interference and Gene Delivery 2
- Genetics 8
- Chronic Lymphocytic Leukemia Research 7
- Co-authors
- Peter L. Bonate (10 shared papers)Daniel D. Von Hoff (4 shared papers)Haiyong Han (1 shared paper)Cory L. Grand (1 shared paper)Rubén M. Muñoz (1 shared paper)Laurence H. Hurley (1 shared paper)David J. Bearss (1 shared paper)Jiří Městecký (1 shared paper)
- Journals
- Clinical Cancer Research (3 papers)Journal of Clinical Oncology (2 papers)Cancer Chemotherapy and Pharmacology (2 papers)Journal of Pediatric Hematology/Oncology (2 papers)Pharmaceutics (1 paper)
- Partner nations
- United StatesCanadaUnited Kingdom
In The Last Decade
Steve Weitman
35 papers receiving 2.4k citations
Peers
Comparison fields: 5 of 127
- Pharmaceutical Science 355
- Molecular Medicine 234
- Biomaterials 304
- Oncology 419
- Molecular Biology 1.1k
Countries citing papers authored by Steve Weitman
This map shows the geographic impact of Steve Weitman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steve Weitman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steve Weitman more than expected).
Fields of papers citing papers by Steve Weitman
This network shows the impact of papers produced by Steve Weitman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steve Weitman. The network helps show where Steve Weitman may publish in the future.
Co-authors
The 25 scholars most cited alongside Steve Weitman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 35 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2001 | 477 | |
| 2 | The cationic porphyrin TMPyP4 down-regulates c-MYC and human telomerase reverse transcriptase expression and inhibits tumor growth in vivo. | 2002 | 322 |
| 3 | 2004 | 215 | |
| 4 | 2006 | 212 | |
| 5 | Development of SU5416, a selective small molecule inhibitor of VEGF receptor tyrosine kinase activity, as an anti-angiogenesis agent. | 2000 | 189 |
| 6 | A phase I study of irinotecan in pediatric patients: a pediatric oncology group study. | 2001 | 98 |
| 7 | 2007 | 94 | |
| 8 | 2016 | 85 | |
| 9 | 2002 | 80 | |
| 10 | 2018 | 71 | |
| 11 | 2002 | 69 | |
| 12 | Enhanced antitumor activity of 6-hydroxymethylacylfulvene in combination with irinotecan and 5-fluorouracil in the HT29 human colon tumor xenograft model. | 1999 | 61 |
| 13 | 2000 | 47 | |
| 14 | The new dioxolane, (-)-2'-deoxy-3'-oxacytidine (BCH-4556, troxacitabine), has activity against pancreatic human tumor xenografts. | 2000 | 47 |
| 15 | 2006 | 45 | |
| 16 | Elevated expression of DNA ligase I in human cancers. | 2001 | 44 |
| 17 | 2005 | 38 | |
| 18 | 2005 | 35 | |
| 19 | 2004 | 35 | |
| 20 | 2002 | 34 |
About Steve Weitman
Steve Weitman is a scholar working on Molecular Biology, Genetics, Oncology, Public Health, Environmental and Occupational Health and Pharmaceutical Science, having authored 35 papers that have together received 2.5k indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (7 papers), Cancer therapeutics and mechanisms (6 papers), Acute Lymphoblastic Leukemia research (4 papers), Nanoparticle-Based Drug Delivery (3 papers), Cancer Treatment and Pharmacology (3 papers), Advanced Drug Delivery Systems (3 papers), Muscle metabolism and nutrition (2 papers) and RNA Interference and Gene Delivery (2 papers). The work is most often cited by research in Pharmaceutical Science (355 citations), Molecular Medicine (234 citations), Biomaterials (304 citations), Oncology (419 citations) and Molecular Biology (1.1k citations). Steve Weitman has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Peter L. Bonate, Daniel D. Von Hoff, Haiyong Han, Cory L. Grand, Rubén M. Muñoz, Laurence H. Hurley, David J. Bearss, Jiří Městecký, Gaylen M. Zentner and Michael Morgan. Their work appears in journals such as Clinical Cancer Research, Journal of Clinical Oncology, Cancer Chemotherapy and Pharmacology, Journal of Pediatric Hematology/Oncology and Pharmaceutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.